QuoTrend
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNews
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNewsMore
⌘K
Help
QuoTrend
PAGEHome
HomePricingContactHelpTermsPrivacy
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
© 2026 QuoTrend
Screen

MAZE

QT52Maze Therapeutics, Inc.
NASDAQ·Healthcare·Biotechnology·USA
Latest market price
25.68
+0.84+3.38%
OverviewShort InterestFilings
MAZEQT52Maze Therapeutics, Inc.·NASDAQ
OverviewShort InterestFilings
25.68+3.38%
TA
Loading chart...
Screen all →
VRTX-1.60%$451.63REGN+0.33%$609.94ARGX-1.63%$877.72ALNY-1.64%$278.09RVMD+3.31%$162.99MRNA+3.50%$63.96UTHR-2.70%$536.59BNTX-1.44%$90.89
Snapshot
Index-P/E-EPS (ttm)
-
Insider Own10.69%
Shs Outstand55.35M
Perf Week6.60%
Market Cap1.37BForward P/E-EPS next Y-3.22Insider Trans0.60%Shs Float-Perf Month4.99%
Enterprise Value1.24BPEG0.01EPS next Q-0.76Inst Own-Short Float-Perf Quarter-48.05%
Income-125792028.00P/S68.74EPS this Y-Inst Trans-Short Ratio-Perf Half Y-36.36%
Sales20.00MP/B3.92EPS next Y-17.15%ROA-29.20%Short Interest-Perf YTD-38.02%
Book/sh6.18P/C-EPS next 5Y-ROE-36.63%52W High53.65 -52.13%Perf Year107.26%
Cash/sh6.36P/FCF-EPS past 3/5Y-ROIC-33.24%52W Low9.83 161.24%Perf 3Y-
Dividend Est.-EV/EBITDA-10.35Sales past 3/5Y-Gross Margin92.04%Volatility2.98% 3.37%Perf 5Y-
Dividend TTM-EV/Sales61.86EPS Y/Y TTM-3351.93%Oper. Margin-670.25%ATR (14)1.30Perf 10Y-
Dividend Ex-Date-Quick Ratio17.88Sales Y/Y TTM-Profit Margin-612.71%RSI (14)52.49Recom1.80
Dividend Gr. 3/5Y-Current Ratio17.88EPS Q/Q60.87%SMA202.92%Beta1.06Target Price63.25
Payout0.00%Debt/Eq0.18Sales Q/Q-SMA50-0.38%Rel Volume2.09Prev Close24.84
Employees125LT Debt/Eq0.05EarningsAug 11SMA200-24.04%Avg Volume666.53KPrice25.68
IPO DateJan 31, 2025Option/ShortYes / YesEPS/Sales Surpr.-4.65% 81.82%Net Debt/EBITDA1.15Volume1,390,454Change3.38%
Analyst Ratings
DateActionAnalystRatingTarget
Apr-14-26ReiteratedTruist Financial$68 → $64
Mar-17-26ReiteratedTruist Financial$68
Mar-10-26InitiatedMizuhoOutperform$97
Jan-16-26ReiteratedBTIGBuy$30 → $46
Dec-19-25ReiteratedGuggenheimBuy$34 → $46
Dec-04-25InitiatedWells FargoOverweight$55
Dec-03-25ReiteratedH.C. Wainwright$50 → $60
Nov-13-25InitiatedRaymond JamesStrong Buy$48
Sep-15-25ReiteratedGuggenheimBuy$34
Sep-02-25InitiatedBTIGBuy$30
Latest News
Company
Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements
DataTimeframe
Line Item (USD, M)
FY 2025
12/31/2025
FY 2024
12/31/2024
FY 2023
12/31/2023
FY 2022
12/31/2022
Total Revenue01680
Upgrade your experience to unlock full historical data
Cost of Goods Sold Incl. D&A200
Gross Profit-21680
Selling, General and Administrative Excl. Other342625
Research and Development1088374
Other Operating Expense-210
Operating Income-14358-99
Interest Expense
000
Unusual Expense
———
Non-Operating Income (Expense)-1242
Net Income Before Taxes-13153-100
Income Taxes010
Consolidated Net Income-13152-100
Net Income From Continuing Operations-13152-100
Net Income-13152-100
EPS (Recurring)-3.050.08-2.29
EPS (Basic, Before Extraordinaries)-3.050.08-2.29
EPS (Diluted)-3.050.08-2.29
EBITDA-12957-96
Other After Tax Adjustments
———
Stock Option Compensation Expense
———
Price To Earnings Ratio
———
Price To Sales Ratio
———
Gross Margin—100.00—
Operating Margin—34.52—
Net Margin—30.95—
Shares Outstanding434444
Market Capitalization1,781——
Operating Lease Expense
———
Insider Trading Volume
$29.05$26.72$24.38$22.05$19.72● Close Price0.00M1.34M2.69M4.03M5.37MUSD Trades VolumeJunJulAugSepOctNovDec2026FebMarAprMayJun
Insider Trading
InsiderRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Form 4
Bernstein HaroldPresident, R&D & CMOJun 01 '26Option Exercise10.4229,706309,536207,554Jun 03 12:00 AM
Coloma Jason VChief Executive OfficerJun 01 '26Sale26.206,643174,04827,970Jun 03 12:00 AM
Bernstein HaroldPresident, R&D & CMOJun 01 '26Sale25.6614,853381,1120Jun 03 12:00 AM
Dandekar AtulCSBOMay 29 '26Option Exercise10.4215,000156,30036,643Jun 02 12:00 AM
Dandekar AtulCSBOMay 29 '26Sale26.347,500197,55424,808Jun 02 12:00 AM
Coloma Jason VChief Executive OfficerMay 26 '26Sale26.0225,582665,516350,987May 27 12:00 AM
Coloma Jason VChief Executive OfficerMay 22 '26Sale26.006,982181,53228,523May 27 12:00 AM
Coloma Jason VChief Executive OfficerMay 15 '26Sale26.001,93850,38831,001May 18 12:00 AM
Bernstein HaroldPresident, R&D & CMOMay 14 '26Option Exercise10.4230,000312,600222,407May 18 12:00 AM
Bernstein HaroldPresident, R&D & CMOMay 14 '26Sale26.2215,000393,3540May 18 12:00 AM
Dandekar AtulCSBOMay 04 '26Option Exercise10.4228,610298,11627,725May 06 12:00 AM
Dandekar AtulCSBOApr 29 '26Option Exercise10.4215,000156,30044,143May 01 12:00 AM
Dandekar AtulCSBOApr 29 '26Sale25.377,500190,29910,503May 01 12:00 AM
Bernstein HaroldPresident, R&D & CMOApr 01 '26Sale29.4615,000441,9040Apr 02 12:00 AM
Bernstein HaroldPresident, R&D & CMOApr 01 '26Option Exercise10.4230,000312,600237,407Apr 02 12:00 AM
open in yahoo·open in reuters·open in marketwatch·open in google·open in EDGAR